Lipid-based drug delivery systems in the treatment of wet age-related macular degeneration

Joanne D Du, Wye-Khay Fong, Suzanne Caliph, Ben J Boyd

Research output: Contribution to journalReview ArticleResearchpeer-review

5 Citations (Scopus)

Abstract

Recent advances in drug delivery technology have amplified potential opportunities to treat the debilitating diseases that affect the posterior segment of the eye in a less invasive and more efficient manner. Current methods for effective drug delivery to the back of the eye are hindered by many barriers and limitations. As a consequence, considerable efforts have been directed towards developing new materials to selectively deliver drug directly to the target site. This review focuses on lipid-based delivery systems which show promise in improving treatment for the most common disease of the posterior segment of the eye in the developed world, age-related macular degeneration, with an emphasis upon on-demand delivery systems as they have greater potential to overcome the current limitations.

Original languageEnglish
Pages (from-to)781-792
Number of pages12
JournalDrug Delivery and Translational Research
Volume6
Issue number6
DOIs
Publication statusPublished - 1 Dec 2016

Keywords

  • Age-related macular degeneration
  • Intravitreal
  • Lipids
  • Liposomes
  • Stimuli responsive

Cite this

@article{5cf337479d1848988cf87fe1819419fc,
title = "Lipid-based drug delivery systems in the treatment of wet age-related macular degeneration",
abstract = "Recent advances in drug delivery technology have amplified potential opportunities to treat the debilitating diseases that affect the posterior segment of the eye in a less invasive and more efficient manner. Current methods for effective drug delivery to the back of the eye are hindered by many barriers and limitations. As a consequence, considerable efforts have been directed towards developing new materials to selectively deliver drug directly to the target site. This review focuses on lipid-based delivery systems which show promise in improving treatment for the most common disease of the posterior segment of the eye in the developed world, age-related macular degeneration, with an emphasis upon on-demand delivery systems as they have greater potential to overcome the current limitations.",
keywords = "Age-related macular degeneration, Intravitreal, Lipids, Liposomes, Stimuli responsive",
author = "Du, {Joanne D} and Wye-Khay Fong and Suzanne Caliph and Boyd, {Ben J}",
year = "2016",
month = "12",
day = "1",
doi = "10.1007/s13346-016-0299-6",
language = "English",
volume = "6",
pages = "781--792",
journal = "Drug Delivery and Translational Research",
issn = "2190-393X",
publisher = "Springer-Verlag London Ltd.",
number = "6",

}

Lipid-based drug delivery systems in the treatment of wet age-related macular degeneration. / Du, Joanne D; Fong, Wye-Khay; Caliph, Suzanne; Boyd, Ben J.

In: Drug Delivery and Translational Research, Vol. 6, No. 6, 01.12.2016, p. 781-792.

Research output: Contribution to journalReview ArticleResearchpeer-review

TY - JOUR

T1 - Lipid-based drug delivery systems in the treatment of wet age-related macular degeneration

AU - Du, Joanne D

AU - Fong, Wye-Khay

AU - Caliph, Suzanne

AU - Boyd, Ben J

PY - 2016/12/1

Y1 - 2016/12/1

N2 - Recent advances in drug delivery technology have amplified potential opportunities to treat the debilitating diseases that affect the posterior segment of the eye in a less invasive and more efficient manner. Current methods for effective drug delivery to the back of the eye are hindered by many barriers and limitations. As a consequence, considerable efforts have been directed towards developing new materials to selectively deliver drug directly to the target site. This review focuses on lipid-based delivery systems which show promise in improving treatment for the most common disease of the posterior segment of the eye in the developed world, age-related macular degeneration, with an emphasis upon on-demand delivery systems as they have greater potential to overcome the current limitations.

AB - Recent advances in drug delivery technology have amplified potential opportunities to treat the debilitating diseases that affect the posterior segment of the eye in a less invasive and more efficient manner. Current methods for effective drug delivery to the back of the eye are hindered by many barriers and limitations. As a consequence, considerable efforts have been directed towards developing new materials to selectively deliver drug directly to the target site. This review focuses on lipid-based delivery systems which show promise in improving treatment for the most common disease of the posterior segment of the eye in the developed world, age-related macular degeneration, with an emphasis upon on-demand delivery systems as they have greater potential to overcome the current limitations.

KW - Age-related macular degeneration

KW - Intravitreal

KW - Lipids

KW - Liposomes

KW - Stimuli responsive

UR - http://www.scopus.com/inward/record.url?scp=85014058063&partnerID=8YFLogxK

U2 - 10.1007/s13346-016-0299-6

DO - 10.1007/s13346-016-0299-6

M3 - Review Article

VL - 6

SP - 781

EP - 792

JO - Drug Delivery and Translational Research

JF - Drug Delivery and Translational Research

SN - 2190-393X

IS - 6

ER -